You are here: Industry Insights > Vaccines

News List

The Growth of Vaccines Beyond Infectious Disease Suzanne Elvidge
April 19, 2024
Vaccination for infectious diseases saves two to three million lives a year worldwide, according to the World Health Organization (WHO).
Breakthroughs in Melanoma Immunotherapy & RNA Vaccines Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
New Improvement in Universal Vaccines and Long-acting Neutralizing Antibodies PharmaSources/Yefenghong
May 25, 2022
COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
Demand for High-End COVID-19 Vaccines to Drive Growth of Excipients Market SHEM OIRERE
December 17, 2021
The COVID-19 pandemic has infected 247 million people and killed five million others as of November 01, 2021 the situation still looks grim due to the high infection rates, the prolonged SARS-CoV-2 virus...
Where Are the Oral COVID-19 Vaccines Stand Now? Lin Zhang
December 17, 2021
The novel coronavirus, SARS-CoV-2, has led to an unprecedented international health crisis and is continuing its spread across the world, with more than 218 million confirmed cases of COVID-19, including more than 4.5 million deaths, reported to the WHO a
Money and Myths Surrounding the COVID-19 Vaccines PharmaSources/Nik Patel
December 02, 2021
Covid vaccines have demonstrated themselves to be highly effective, reducing the need for hospitalisation and risk of death by a massive 95%.
How Much Money Do Pharmaceutical Companies Really Make From COVID-19 Vaccines? Lin Zhang
October 28, 2021
The COVID-19 pandemic led to widespread effects across the world, leading not only to economic challenges but also to advancements in medicine and pharmaceutical development.
Updates for the Janssen and AstraZeneca Vaccines Cross-contamination Lin Zhang
July 13, 2021
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes COVID-19 pandemic has spread to over 220 countries and territories around the world as of July 2021.
Artificial Intelligence and COVID-19 Vaccines Lin Zhang
May 31, 2021
In recent years, AI, in general, is becoming a popular tool in the pharmaceutical industry, not just in the case of COVID specifically.
A Review of the Current Situation of COVID-19 R&D in China with Two More COVID-19 Vaccines Marketed PharmaSources/Yefenghong
May 31, 2021
On Feb. 25, the National Medical Products Administration of China (NMPA) conditionally approved the registration applications of two COVID-19 vaccines: Inactivated COVID-19 Vaccine (Vero Cell) of Sinopharm Wuhan Institute of Biological Products Co., Ltd.